Back
Corcept Therapeutics Stock Price Chart
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
39
CORT
Corcept Therapeutics
Last Price:
$62.21
Seasonality Move:
2.94%
7 Day Trial
ALL ACCESS PASS
$
7
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
The current trend is moderately bullish and CORT is experiencing selling pressure, which indicates risk of future bearish movement.
Corcept Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 67.96 | Sell |
| 20-day SMA: | 70.35 | Sell |
| 50-day SMA: | 65.64 | Sell |
| 200-day SMA: | 50.63 | Buy |
| 8-day EMA: | 67.47 | Sell |
| 20-day EMA: | 61.32 | Buy |
| 50-day EMA: | 39.81 | Buy |
| 200-day EMA: | 13.23 | Buy |
Corcept Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 10.87 | Buy |
| Relative Strength Index (14 RSI): | 45.43 | Sell |
| Chaikin Money Flow: | -1300725 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.28 - 81.16) | Sell |
| Bollinger Bands (100): | (51.56 - 70.54) | Buy |
Corcept Therapeutics Technical Analysis
| Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Corcept Therapeutics Stock
Is Corcept Therapeutics Stock a Buy?
-
Corcept Therapeutics share price is 62.24 while CORT 8-day simple moving average is 67.96, which is a Sell signal.
-
The stock price of CORT is 62.24 while Corcept Therapeutics 20-day SMA is 70.35, which makes it a Sell.
-
Corcept Therapeutics 50-day simple moving average is 65.64 while CORT share price is 62.24, making it a Sell technically.
-
CORT stock price is 62.24 and Corcept Therapeutics 200-day simple moving average is 50.63, creating a Buy signal.
CORT Technical Analysis vs Fundamental Analysis
Sell
39
Corcept Therapeutics (CORT)
is a Sell
Is Corcept Therapeutics a Buy or a Sell?
-
Corcept Therapeutics stock is rated a SellThe current Corcept Therapeutics [CORT] share price is $62.24. The Score for CORT is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
Corcept Therapeutics Stock Info
Market Cap:
6.6B
Price in USD:
62.24
Share Volume:
1.6M
Corcept Therapeutics 52-Week Range
52-Week High:
117.33
52-Week Low:
20.84
Sell
39
Corcept Therapeutics (CORT)
is a Sell
Corcept Therapeutics Share Price Forecast
-
What is the Corcept Therapeutics stock price today?The Corcept Therapeutics stock price is 62.24 USD today.
-
Will CORT stock go up or go down?Corcept Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Corcept Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Corcept Therapeutics is overvalued.
Is Corcept Therapeutics Stock a Buy?
-
Corcept Therapeutics share price is 62.24 while CORT 8-day exponential moving average is 67.47, which is a Sell signal.
-
The stock price of CORT is 62.24 while Corcept Therapeutics 20-day EMA is 61.32, which makes it a Buy.
-
Corcept Therapeutics 50-day exponential moving average is 39.81 while CORT share price is 62.24, making it a Buy technically.
-
CORT stock price is 62.24 and Corcept Therapeutics 200-day simple moving average is 13.23, creating a Buy signal.
Fundamental Analysis of Corcept Therapeutics
Is Corcept Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.29 per share, and an increase next year of $1.64 per share.
Technical Analysis of Corcept Therapeutics
Should I short Corcept Therapeutics stock?
-
CORT Moving Average Covergence Divergence (MACD) indicator is 10.87, suggesting Corcept Therapeutics is a Buy
-
Corcept Therapeutics Relative Strength Index (RSI) is 45.43, which suggest Corcept Therapeutics is oversold
-
The Bollinger Bands (25) for Corcept Therapeutics is (54.28 - 81.16), which suggest Corcept Therapeutics is a Buy
-
The Bollinger Bands (100) for Corcept Therapeutics is (51.56 - 70.54), which suggest Corcept Therapeutics is a Buy
* Corcept Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.